Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for global professionals · Sunday, February 25, 2018 · 434,040,050 Articles · 3+ Million Readers

Corrigan Named CEO Of CombinatoRx

January 7, 2010 (FinancialWire) — CombinatoRx, Inc. (NASDAQ: CRXX) has named Mark Corrigan, MD, the former EVP of Research & Development at Sepracor and a member of the CombinatoRx board of directors, to the role of president and chief executive officer of CombinatoRx. Christopher Gallen, MD, Ph.D., former CEO of Neuromed, will serve as the firm’s executive vice president of Research and Development.

Robert Forrester has decided to leave his position at the company to pursue other opportunities.

The moves follow CombinatoRx’s recently completed merger with Neuromed.

CombinatoRx develops novel drug candidates with a focus on the treatment of pain and inflammation.

Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at Recently issued reports and filings include Weatherford International Ltd. (NYSE: WFT), UQM Technologies, Inc. (AMEX: UQM), Panhandle Oil and Gas, Inc. (NYSE: PHX), Encore acquisition Company (NYSE: EAC), Altius Minerals Corp. (TSX: ALS), PKC Group Oyj (PLUS: PKC1V) and Standard Life Investments European Private Equity Trust PLC (LSE: SEP) (PLUS: SEP).

FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” ( Recently webcast company presentations, financial results & earnings calls now available include Rick’s Cabaret International, Inc. (NASDAQ: RICK) and Applied Signal Technology, Inc. (NASDAQ: APSG). Recordings are accessible via the search function at by entering any company’s ticker symbol into the search field.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) website ( Contact FinancialWire(tm) directly via

Powered by EIN Presswire